Lung Cancer in Colombia

Fecha de publicación: 01/01/2022 Fecha Ahead of Print: 01/08/2022

Autores organización

Andres Felipe Cardona Mendoza

Autor
Luis Leonardo Rojas Beltran

Autor

Autores

Mejía S.A.
Viola L.
Chamorro D.F.
Ruíz-Patiño A.
Serna A.
Martínez S.
Muñoz Á.
Rodríguez J.
García-Robledo J.E.
Pino L.E.
Zatarain-Barrón Z.L.
Arrieta O.

Grupos de investigación

Grupo de Inmunología celular y molecular Universidad El Bosque (InmuBo)

Investigador

Maria Consuelo Romero Sanchez

Resumen

[No abstract available]

Datos de la publicación

ISSN/ISSNe:: 1556-0864, 1556-1380
Tipo:: Editorial Material
Páginas:: 953-960
DOI:: 10.1016/j.jtho.2022.02.015
PubMed:: 35717323
Enlace a otro recurso:: www.scopus.com

Documentos

No hay documentos

Métricas

Filiaciones

Cardona A.F.:: Direction of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia

Foundation for Clinical and Applied Cancer Research—FICMAC, Bogotá, Colombia

Universidad. Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia
Mejía S.A.:: Cancer Institute, Clinica las Americas - AUNA, Medellin, Colombia
Viola L.:: Thoracic Oncology Unit, Fundación Neumológica Colombiana, Bogotá, Colombia
Chamorro D.F.:: Foundation for Clinical and Applied Cancer Research—FICMAC, Bogotá, Colombia

Universidad. Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia
Rojas L.:: Clinical Oncology Department, Clínica Colsanitas, Bogotá, Colombia
Ruíz-Patiño A.:: Foundation for Clinical and Applied Cancer Research—FICMAC, Bogotá, Colombia

Universidad. Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia
Serna A.:: Thoracic Surgery Department, Marly Clinic “Jorge Cavelier Gaviria,” Chía, Cundinamarca, Colombia
Martínez S.:: Thoracic Surgery Department, Clínica Colsanitas, Cundinamarca, Bogotá, Colombia
Muñoz Á.:: Radiation Oncology Department, Carlos Ardila Lülle Cancer Institute—ICCAL, Fundación Santa Fe de Bogotá, Bogotá, Colombia
Rodríguez J.:: Foundation for Clinical and Applied Cancer Research—FICMAC, Bogotá, Colombia

Universidad. Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia
Pino L.E.:: Clinical Oncology Department, Carlos Ardila Lülle Cancer Institute—ICCAL, Fundación Santa Fe de Bogotá, Bogotá, Colombia
Zatarain-Barrón Z.L.:: Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), México, México City, Mexico
Arrieta O.:: Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), México, México City, Mexico

Keywords

Colombia; Humans; Lung Neoplasms; afatinib; alectinib; atezolizumab; bevacizumab; brigatinib; crizotinib; docetaxel; erlotinib; gefitinib; gemcitabine; ipilimumab; larotrectinib; nintedanib; nivolumab; osimertinib; paclitaxel; pembrolizumab; vinorelbine tartrate; air pollution; cancer chemotherapy; cancer diagnosis; cancer incidence; cancer mortality; cancer radiotherapy; cancer risk; cancer screening; cancer staging; Colombia; computer assisted tomography; diet; early cancer diagnosis; Editorial; geographic distribution; health care cost; health care system; human; lung cancer; lung carcinogenesis; molecular epidemiology; non small cell lung cancer; occupational exposure; phenotype; practice guideline; prevalence; risk factor; social status; systemic therapy; thorax radiography; thorax surgery; tobacco use; Colombia; lung tumor